Which is the factual basis, in theory and clinical practice, for the use of vaccinia immune globulin for the prevention or attenuation of complications of smallpox vaccination?
D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D012712:Serum Globulins / Q000627:therapeutic use*; D012900:Smallpox Vaccine / Q000009:adverse effects*; D014616:Vaccinia virus / Q000276:immunology
D012712:Serum Globulins; D012900:Smallpox Vaccine